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Abstract. Pediatric pulmonary tuberculosis diagnosis is difficult because young children are unable to expectorate
sputum samples. Testing stool for tuberculosis DNA from swallowed sputum may diagnose pulmonary tuberculosis.
Hospitalized children with suspected tuberculosis had stool, nasopharyngeal, and gastric aspirates cultured that con-
firmed pulmonary tuberculosis in 16/236 patients. Twenty-eight stored stools from these 16 children were used to
evaluate stool polymerase chain reaction (PCR) for tuberculosis diagnosis compared with 28 stool samples from 23
healthy control children. Two DNA extraction techniques were used: fast-DNA mechanical homogenization and
Chelex-resin chemical extraction. DNA was tested for tuberculosis DNA with a hemi-nested IS6110 PCR. PCR after
Fast-DNA processing was positive for 6/16 culture-proven tuberculosis patients versus 5/16 after Chelex extraction
(sensitivity 38% and 31%, respectively). All controls were negative (specificity 100%). If sensitivity can be increased,
stool PCR would be a rapid, non-invasive, and relatively bio-secure initial test for children with suspected pulmonary
tuberculosis.
INTRODUCTION
Tuberculosis kills ∼2 million people each year, and in 1989,
the World Health Organization estimated that ∼300,000 chil-
dren < 15 years of age die of tuberculosis per year world-
wide.1,2 Pediatric tuberculosis diagnosis is impeded by diffi-
culty obtaining sputum samples in children and the pauci-
bacillary nature of their disease that often necessitates
invasive procedures such as gastric aspiration or bronchos-
copy3 or reliance on unreliable clinical scoring systems.4 In
South Africa, it has been shown that induced sputum has
comparable diagnostic sensitivity to gastric aspirate in HIV-
positive and -negative children,5 whereas some other studies
have shown less promising results for induced sputum.6 Al-
though less invasive than gastric aspirates, induced sputum is
still unpleasant and requires precautions to prevent airborne
tuberculosis transmission to staff and other patients.3 If tu-
berculosis could be diagnosed from stool, collection could
easily take place in the field or in clinics.
The important issues and challenges in pediatric tubercu-
losis differ markedly between developed and developing
countries. In more developed countries such as the United
States, rates of tuberculin skin test reactivity in the general
population are low, so the tuberculin skin test is a useful
diagnostic test for tuberculosis. In contrast, in many develop-
ing countries such as Peru, interpretation of the tuberculin
skin test for diagnosis of pulmonary tuberculosis is less reli-
able.7,8 The diagnostic yield of gastric aspiration ranges from
20% to 40%.3,9 Although children and infants may be unable
to expectorate sputum samples, most sputum is swallowed,9
and tuberculosis DNA may remain intact after intestinal tran-
sit. We and others have shown that the IS6110 polymerase
chain reaction (PCR) test is both sensitive and specific for
detecting Mycobacterium tuberculosis in respiratory samples
in adults and gastric aspirates in children.10–14 We have also
shown that M. tuberculosis DNA can be detected by the
above method in stool samples from adults with pulmonary
tuberculosis (J Cordova and others, unpublished data). How-
ever, sensitivity was affected by DNA extraction methods.
We therefore did this research to test two hypotheses: first,
that stool PCR could be used to diagnose pediatric pulmonary
tuberculosis as an alternative to invasive procedures in pedi-
atric patients with suspected pulmonary tuberculosis; second,
that the sensitivity of stool PCR could be improved by opti-
mizing the DNA extraction technique.
MATERIALS AND METHODS
Subjects. A long-term clinical trial in Lima, Peru, has been
evaluating pediatric tuberculosis diagnostic strategies, as re-
ported.4 Children < 12 years of age were enrolled if there was
a high clinical suspicion of tuberculosis indicated by a Stegen
and Toledo15 score  5, provided that they were HIV nega-
tive and had not received tuberculosis treatment. Gastric as-
pirates, nasopharyngeal aspirates,16 and stool samples were
collected on 2 consecutive days. If stool samples were not
available on consecutive days, the first subsequent stool
sample was substituted. Samples were tested for tuberculosis
by auramine microscopy17 and culture using the microscopic-
observation drug-susceptibility (MODS) technique.18,19 All
patients with a clinical or culture proven diagnosis of tuber-
culosis were provided with standard anti-tubercular chemo-
therapy by the national tuberculosis control program.1
As negative controls, stool samples and nasopharyngeal as-
pirates were also tested from asymptomatic children living in
a well-described Peruvian peri-urban shantytown.8,20,21 These
age-matched control children all had normal clinical exami-
nations, no tuberculosis risk factors, and negative tuberculin
skin tests (< 10-mm induration after 5 IU intradermal 0.1-mL
injection of Tubersol; Aventis Pasteur, Toronto, Canada).
Stool samples without additives from all patients and controls
were stored for up to 2 years at −20°C.
The study protocol and consents were approved by the
institutional review boards at Tulane Medical Center, Johns
Hopkins Bloomberg School of Public Health, Association
Benefica PRISMA, and the Instituto de Salud del Niño of
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Lima, Peru. Written informed consent was obtained from all
patients or their parents or guardians, and the human experi-
mentation guidelines of the US Department of Health and
Human Services were followed.
Two years after the beginning of the study, we found that a
recently developed Fast-DNA extraction method increased
tuberculosis PCR detection from adult patients’ stool speci-
mens. Because of this new knowledge, a study was set up
using the stored stool samples from pediatric patients who
had a positive M. tuberculosis culture compared with stored
stool samples from healthy controls. Laboratory personnel,
blinded to the nature of the samples, extracted DNA from one
half of each sample using 1) Fast-DNA homogenization and
from the other half using 2) Chelex resin extraction. IS6100 PCR
was performed on the DNA samples for tuberculosis detection.
Fast DNA extraction method. Stool (200 mg) was homog-
enized with 1 mL phosphate buffer, transferred to a lysing
matrix tube with 125 L of homogenization buffer, and pro-
cessed in the FastPrep instrument (Qbiogene, Irvine, CA) for
30 seconds at speed 5.5. The product was centrifuged at
14,000g for 1 minute, and 250 L of protein precipitation
solution was added to the supernatant. The product was cen-
trifuged at 14,000g for 15 minutes, and the supernatant was
processed according to the manufacturer’s instructions with
the DNA product eluted in 60 L of water.
Chelex extraction and stool decontamination. A stool
sample (200 mg) was homogenized in 6 mL of water, and 2
mL of the supernatant was decontaminated with n-acetyl-L-
cysteine and sodium hydroxide for 15 minutes as de-
scribed.11,14,17 Ethanol was added to a final concentration of
60% to kill the mycobacteria. The decontaminated pellet was
washed with TE-Triton X-100 buffer and resuspended in 100
L of Chelex 10%/Triton X-100 1% TE. The samples were
boiled for 30 minutes, cooled at −20°C for 10 minutes, and
centrifuged at 6,000g for 5 minutes, and the 3-L supernatant
was used for PCR.11
Dilution. The DNA products were tested using PCR both
directly and after 1:5 dilution to decrease inhibitors. Dilutions
were made in DNAse and pyrogen-free water for Fast-DNA
and in Triton-Tris-EDTA for Chelex.17
IS6110-PCR procedure. Hemi-nested PCR reactions were
performed on each sample, using 0.22 mmol/L outer and 0.52
mmol/L inner primers that have been shown to be specific to
M. tuberculosis, as described.11,13,22 Duplicate PCR reactions
were performed for each sample with Taq polymerase
(Promega, Madison, WI) and TaqStart (Clontech, Mountain
View, CA). Negative PCR controls consisted of the PCR mix-
ture without sample. Positive PCR controls were auramine-
negative gastric aspirate culture-positive pediatric samples.
The IS6110-PCR (Genbank accession M29899) protocol took
< 6 hours to perform.
Statistical analysis. The gold standard for a diagnosis of
proven tuberculosis was M. tuberculosis isolation in labora-
tory culture. Sensitivity and specificity with 95% confidence
intervals were estimated for each test. Proportions were com-
pared using Z-tests for proportions. All tests were two-tailed
and were performed under a 95% confidence level with the
statistical software STATA 9.0 (Statacorp, College Station, TX).
RESULTS
The study standards for reporting of diagnostic accuracy
flow chart is shown in Figure 1, and the patient characteristics
are shown in Table 1. Four patients were female, and there
were no significant sex differences for patients and controls
(P 0.2). Tuberculin skin tests were positive for 14/16 (87%)
of tuberculosis cases. The mean Stegen and Toledo score for
tuberculosis cases was 7.4%, and 69% had a score  7, indi-
cating highly probable tuberculosis.
The mean age of the controls was 7.4 years, which was
significantly greater than the patients (4.4 years; P  0.01).
All of the controls had a negative tuberculin skin test and a
Stegen and Toledo score of zero.
Table 2 shows that stool specimens with DNA extracted by
the Fast-DNA method were PCR positive in 6/16 culture-
positive patients versus 5/16 patients when stool was extracted
by the Chelex method (sensitivity 38% versus 31%, respec-
tively, P  0.7). Figure 2 shows the contribution of second
samples to diagnostic sensitivity.
Table 2B shows that, among samples from the 16 culture
positive patients, 9/28 (32%) were PCR positive in samples
extracted by Fast DNA compared with 6/28 (21%) extracted
by Chelex. Although Fast DNA tended to be more sensitive
than Chelex, the difference was not statistically significant
(P 0.3). The results from Fast-DNA and Chelex tests were
highly concordant with 75% agreement ( 0.37, P 0.02).
None of the 28 samples from 23 control participants were
positive by PCR with stool DNA extracted by either Fast
DNA or Chelex (100% specificity).
All patients with culture-proven tuberculosis had at least
one gastric culture–positive specimen (diagnostic sensitivity
by patient, 100%), whereas 20/28 gastric aspirate samples
from these patients were culture positive versus 9/27 naso-
pharyngeal aspirate cultures (sensitivity by diagnostic sample
71% versus 31%, respectively, P  0.01). Gastric aspirates
were not collected from controls, but all of the 28 nasopha-
ryngeal cultures from the 23 controls were culture negative
(100% specificity).
PCR assays were performed on both undiluted stools and
stools diluted 1:5 in aqueous solutions, as described above.
For both the Chelex and Fast-DNA extraction sample prod-
ucts, the 1:5 diluted samples had greater sensitivity than the
undiluted specimens, yielding all but one of the positive PCR
results (5/28 [18%] by Chelex and 8/28 [29%] by Fast DNA).
The DNA extracts from the Chelex and Fast-DNA undiluted
samples were less adequate for PCR than the diluted DNA
extracts, yielding positive results in 4/28 (14%) and 5/28
(18%) specimens, respectively.
Table 3 shows clinical risk factors associated with a positive
stool PCR result. Stool PCR was significantly more likely to
be positive in samples from tuberculosis patients with cough
for > 2 weeks, patients with a culture-positive paired speci-
men (stool, gastric aspirate, or nasopharyngeal aspirate), and
patients with an auramine stain–positive paired stool sample.
DISCUSSION
This study showed that IS6110-PCR with Fast-DNA stool
sample processing diagnosed pediatric pulmonary tuberculo-
sis with 38% sensitivity and 100% specificity compared with
cultures of multiple samples as the gold standard. Conse-
quently, stool PCR had the same sensitivity as nasopharyn-
geal aspirate cultures. We compared the Fast-DNA extrac-
tion method to Chelex extraction and found no significant
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difference in sensitivity, although the Fast-DNA tended to
perform better. Even though all the patients in this study had
at least one culture positive for tuberculosis, not every sample
tested positive by culture. Culture and PCR testing of dupli-
cate clinical specimens with multiple laboratory methodolo-
gies increased diagnostic sensitivity, suggesting that speci-
mens were close to the threshold of detection sensitivity in
this paucibacillary childhood infection.
Diagnosing tuberculosis in stool using a DNA extraction
method and hemi-nested IS6110 PCR assay is potentially a
useful initial test for tuberculosis in children, especially if sen-
sitivity can be increased. Patients who test positive may avoid
multiple invasive procedures. Furthermore, stool PCR took 1
day, implying that some pediatric tuberculosis cases could be
identified much more quickly than the several weeks required
for tuberculosis culture. It would also be possible to detect
rifampicin resistance using the heteroduplex technique that
we have reported,11,23 although culture-based testing showed
that none of these strains were rifampicin resistant and het-
eroduplex-PCR was therefore not performed in this study.
TABLE 1
Patient characteristics
Characteristic Patients (N  16)
Patient age (years)
Median age (IQR) 5.05
Mean years ± SD 4.42 ± 3.04
Range 3 weeks to 11 years
Ratio of males to females 12:4
Stegen and Toledo score
Mean Stegen Toledo score ± SD 7.44 ± 2.28
Score of  7 (highly probable
tuberculosis)
11 (69%)
Range 5–13 (probable to highly-
probable tuberculosis)
Tuberculin skin test positive
( 10 mm)
14 (88%)
Cough > 2 weeks 6 (38%)
Suspect radiograph 11 (69%)
Pulmonary infiltrate on radiograph 2 (13%)
Contact with adult tuberculosis patient 14 (88%)
The distribution of the patient population is shown, characterizing demographics and
clinical Stegen and Toledo score and its respective components.
FIGURE 1. Standards for reporting of diagnostic accuracy flow chart.
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This proof of principle study showed that stool PCR has the
capacity to diagnose pediatric tuberculosis. Ongoing research
aims to increase sensitivity to make stool PCR a valuable
initial test for children with suspected pulmonary tuberculo-
sis. The greater sensitivity of diluted compared with undiluted
stool samples implies the presence of PCR inhibitors in these
clinical samples. The dilution step reduced the adverse effect
of inhibitors on PCR sensitivity but will also have decreased
the concentration of M. tuberculosis DNA, inevitably reduc-
ing diagnostic sensitivity. We are evaluating substituting
DNA concentration and purification columns in place of di-
lution for removing inhibitors while increasing DNA concen-
tration and hence sensitivity.
Studies evaluating pediatric tuberculosis diagnostics are
confounded by the inadequacy of gold standard tests and the
rarity of proven tuberculosis. We focused on children with
culture-proven tuberculosis compared with healthy controls
to evaluate stool PCR compared with a definite gold stan-
dard. However, 472 children had to undergo extensive studies
to define the relatively modest sample sizes involved in the
current research. Although this was probably the optimal
strategy for defining with certainty the sensitivity and speci-
ficity of stool PCR, it should be noted that most children
receiving treatment for pulmonary tuberculosis are culture
negative and only have an uncertain, presumed diagnosis.
Stool PCR positivity would likely be less frequent in clinical
practice involving culture-negative and culture-proven tuber-
culosis, but tuberculosis diagnosis is generally uncertain in
these cases, so implications for the true sensitivity of the test
are difficult to define for culture-negative patients.
When deciding which DNA extraction method to use, vari-
ous factors need to be considered. Chelex ($1/sample mate-
rials) is considerably less expensive than the Fast-DNA kits
($14/sample kit cost, plus single machine purchase), so if the
sensitivity of Chelex extraction could be improved, it would
be ideal. Chelex requires a decontamination process, whereas
Fast-DNA does not. Chelex extraction was technically simple
and rapid, requiring < 2 hours to process 12 samples. The
FIGURE 2. Contribution of second samples to diagnostic sensitivity. The gray bars represent tuberculosis detected by the first sample, whereas
the white bars depict the added diagnostic yield of the second sample. The number above each set of bars represents the number of false negatives.
This graph only includes the 12 patients who had two samples taken. NPA  nasopharyngeal aspirate.
TABLE 2
Stool PCR sensitivity
(A) Analysis by subject
Fast DNA stool PCR Tuberculosis cases (N  16) Healthy controls (N  23) Sensitivity Specificity
Fast PCR (+) 6 0 38% 100%
Fast PCR (−) 10 23
Chelex stool PCR Tuberculosis cases (N  16) Healthy controls (N  23)
Chelex PCR (+) 5 0 31% 100%
Chelex PCR (−) 11 23
(B) Analysis by specimen
Stool and culture
samples from cases
(N  28)
Healthy control samples
(N  28) Sensitivity Specificity
Fast (+) stool PCR 9 0 31% 100%
Fast (−) stool PCR 19 28
Chelex (+) stool PCR 6 0 21% 100%
Chelex (−) stool PCR 22 28
Gastric aspirate culture (+) 20 Not done 71% NA
Gastric aspirate culture (−) 8 Not done
Nasopharyngeal aspirate culture (+) 9 (missing 1) 28 31% 100%
Nasopharyngeal aspirate culture (−) 18 28
The sensitivity and specificity of stool PCR for the detection of M. tuberculosis is shown, analyzed by DNA extraction diagnostic method amongst children with at least one positive TB culture
and from healthy control children. (A) Analysis by subject and (B) analysis by specimen: sensitivity and specificity of stool PCR of gastric aspirate culture and nasopharyngeal culture for detection
of M. tuberculosis.
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Fast-DNA extraction process required commercial kits and
approximately twice as much laboratory time per sample.
Fast-DNA extraction tended to provide greater PCR sensi-
tivity, but this difference was not statistically significant, and
the relative efficiency of these DNA extraction techniques is
the subject of our ongoing research.
Significant predictors that a pediatric tuberculosis patient’s
stool sample would be PCR positive included the presence of
a paired gastric aspirate or stool sample that was auramine
stain positive for mycobacteria. Therefore, stool PCR is more
likely to be positive in patients with microbiological evidence
of increased bacillary load. In many pediatric patients, M.
tuberculosis may never enter the bronchi but instead remain
in the lymph node.24 Children with prolonged cough were
significantly more likely to have a positive stool PCR sample,
probably because they are more likely to have infection in
their bronchus and therefore are more likely to produce spu-
tum that will then be swallowed. Children with a negative
tuberculin skin test were more likely to have a positive stool
PCR sample, probably because an anergic tuberculin skin test
response may indicate more severe tuberculosis with higher
bacillary load.25
A limitation of this study is the small sample population
because of the small proportion of children with suspected
tuberculosis who had a culture-proven diagnosis. However,
this study involved 472 children, one half of whom had sus-
pected pulmonary tuberculosis and underwent extensive in-
vasive testing with > 2,000 laboratory cultures to identify this
number of culture-proven cases. This indicates the low yield
of culture confirmation of tuberculosis in children and em-
phasizes the urgent need for new, more sensitive diagnostic
tests despite the large trials required for their evaluation.
Other limitations include the fact that two stool samples were
not collected from every child with a positive upper gastric-
intestinal aspirate and that it was not always possible to col-
lect the stool sample on the same day as the upper gastric-
intestinal aspirate was performed. For diagnosing pediatric
tuberculosis, two gastric aspirates are usually taken on con-
secutive days to increase sensitivity. This practice was sup-
ported by our study, which also suggested that if two stool
samples were collected from every patient, the sensitivity of
the stool PCR test would improve. The stool samples used in
this study had been stored frozen at −20°C for ∼2 years, which
may have reduced the quantity or integrity of mycobacterial
DNA, potentially reducing the sensitivity of the PCR tests.
Although the specificity was 100%, the number of control
samples was relatively limited, and a larger sample size would
be required to confidently determine true specificity.
In conclusion, stool PCR is a specific, moderately sensitive
technique for the diagnosis of pulmonary tuberculosis in cul-
ture-positive pediatric patients and has potential use as a
rapid, non-invasive preliminary test for pediatric tuberculosis.
The DNA extraction and PCR techniques are being refined
to increase diagnostic sensitivity. Because of the high speci-
ficity, a positive stool PCR may allow clinicians to rapidly
identify some children highly likely to have culture-positive pul-
monary tuberculosis and initiate treatment at an earlier stage.
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TABLE 3
Logistic regression of factors associated with a positive PCR result
Stool sample PCR (+)
(N  11)
Stool sample PCR (–)
(N  17) Odds ratio P value
Samples from children with positive
tuberculin skin test
8 17 0 0.03
95% confidence
interval
[0–0.71]
Sample from children with cough for
> 2 weeks
8 4 8.6 0.01
Paired gastric aspirate culture positive 10 10 7 0.066
Stool sample auramine microscopy
positive
3 0 > 1,000* 0.02
At least one paired culture-positive
specimen (gastric aspirate,
nasopharyngeal aspirate, or stool)
11 10 > 1,000* 0.01
Logistic regression of factors associated with a positive PCR result among 28 stool samples from 16 children with culture-proven pulmonary tuberculosis.
The following factors were also studied but did not approach statistical significance: age (older than 5 years), OR  1.2, P  0.8; male sex, Odds ratio (OR)  1.9, P  0.5; Stegen Toledo
score > 7, OR  1.45, P  0.7; suspect radiograph, OR  0.31, P  0.3; pulmonary infiltrate on radiograph, OR  6, P  0.1; contact with adult tuberculosis patient, OR  0.6, P  0.6;
nasopharyngeal aspirate auramine microscopy positive, OR  2.5, P  0.3; gastric aspirate auramine microscopy positive, OR  6, P  0.1; stool culture positive, OR  3.5, P  0.3.
* Because all stool samples with paired culture-positive gastric aspirate samples were PCR positive and no stool sample that was auramine microscopy positive was stool PCR negative, the
odds ratios for these factors approached infinity and therefore cannot be exactly calculated.
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